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Abstract
Background There are mounting calls for robust, critical evaluation
of the impact of patient and public involvement (PPI) in health
research. However, questions remain about how to assess its impact,
and whether it should be assessed at all. The debate has thus far been
dominated by professionals.
Objective To explore the views of PPI contributors involved in
health research regarding the impact of PPI on research, whether
and how it should be assessed.
Design Qualitative interview study.
Setting and participants Thirty-eight PPI contributors involved in
health research across the UK.
Results Participants felt that PPI has a beneﬁcial impact on health
research. They described various impactful roles, which we conceptu-
alize as the ‘expert in lived experience’, the ‘creative outsider’, the ‘free
challenger’, the ‘bridger’, the ‘motivator’ and the ‘passive presence’.
Participants generally supported assessing the impact of PPI, while
acknowledging the challenges and concerns about the appropriateness
and feasibility of measurement. They expressed a range of views about
what impacts should be assessed, by whom and how. Individual feed-
back on impact was seen as an important driver of improved impact
and motivation to stay involved.
Conclusions While there appears to be widespread support for PPI
impact assessment among PPI contributors, their views on what to
assess and how are diverse. PPI contributors should be involved as
equal partners in debates and decisions about these issues. Individual
feedback on impact may increase PPI contributors’ potential impact
and their motivation to stay involved.
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Introduction
Public involvement is deﬁned by NIHR
INVOLVE, the National Institute for Health
Research patient and public involvement advi-
sory group, as ‘research being carried out with
or by members of the public, rather than to,
about or for them’. Members of the public
include patients, potential patients, carers and
people who use health and social care services as
well as people from organizations that represent
people who use services.1 For this reason, it is
also often referred to as ‘patient and public
involvement’ (PPI). Many diﬀerent terms are
used internationally to describe patients and
members of the public involved in research, such
as ‘lay representative’, ‘patient partner’ and
‘public adviser’. In this study, we adopt the term
‘PPI contributor’ to avoid implying either that
the small number of individuals typically
involved in research can represent the diversity
of perspectives among patients and the public or
that the role of PPI contributors can always be
described as a partnership.2
The evidence base for the impact of PPI in
health research is weak and patchy,3–5 and
there are concerns about its implementation
without a thorough justiﬁcation and under-
standing of its impact. Recently, there have
been calls to improve this evidence base and
develop better methods to capture, assess and
report the impact of PPI.6–10 Frameworks such
as the Public Involvement Impact Assessment
Framework (PiiAF)11 and Guidance for
Reporting the Involvement of Patients and the
Public (GRIPP)10 have been developed, and
in-depth realist evaluations have begun to shed
light on what works, for whom, under what
circumstances and why.12,13 There is a general
consensus that although PPI has intrinsic
value, it should be scrutinized and evalu-
ated,14–17 although not everyone agrees that its
impact should be quantitatively measured.18
However, the debate has been dominated by
professionals, with little input from patients
and members of the public. It has been argued
that we need open and honest debate about
what is meant by the need to assess the impact
of PPI, including who beneﬁts from the assess-
ment and why PPI is being done, before we
can conclude that assessment is necessary and
determine how to do it.19 This paper con-
tributes a diverse range of patient and public
views to the ‘impact debate’, as well as shed-
ding light on mechanisms of impact that have
so far been underexplored.8
As part of a wider study exploring views and
experiences of patient and public involvement
across the UK,20 here we report on PPI contribu-
tors’ thoughts and perspectives on the impact of
PPI on research and its assessment. We deﬁne
‘impact’ as any eﬀect, positive or negative, that
PPI contributors have on research processes,
outputs and outcomes, including both an indi-
vidual’s impact within a given project, and the
impact of PPI more generally on research and
research culture. Although not the focus of this
study, the impact of PPI on the people involved
(PPI contributors and researchers) is another
important aspect of impact which merits investi-
gation.11 We deﬁne the ‘assessment’ of impact as
any attempt to judge, either qualitatively or
quantitatively, the eﬀect that PPI has on a
research project or research more generally.
Because an extensive range of impacts of PPI has
already been identiﬁed and reported,3,4,12,13,21 we
only brieﬂy describe the impacts identiﬁed by
participants in this study, focusing more on the
mechanisms and assessment of impact.
Methods
We recruited a maximum variation sample of
patients and members of the public from across
the UK. Advertisements were sent to universities
and clinical research networks and were dis-
tributed among the authors’ professional
networks and at PPI conferences. The partici-
pants had been involved in medical, health or
health-related research for various lengths of
time (see Table 1) in a range of diﬀerent types of
research, from qualitative studies to interna-
tional clinical trials.
Ethical approval for the study was granted by
the Berkshire Research Ethics Committee
(ref:12/SC/0495). Five patients and members of
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the public with PPI experience (including
JB) were involved in the study through an advi-
sory group which also included researchers,
clinical staﬀ and representatives from PPI
organizations. They advised on sampling,
recruitment, the interview guide and themes
emerging from the analysis. Two of them also
participated in the study.
Participants took part in one semi-structured
narrative interview with AMB or LL, the wider
ﬁndings of which are available on the health
website.20 Here, we focus speciﬁcally on their
views about the impact of PPI on research,
elicited using a range of prompts (Box 1).
The interviews were video or audio-recorded
and transcribed verbatim. LL coded the data
with NVivo software (QSR International, Mel-
bourne Australia) using a coding framework
developed jointly with AMB. Coding was an
iterative process; as new codes were added,
previous transcripts were re-coded. JCC then re-
analysed the coding report on ‘value and
impact’, using a more reﬁned coding framework
developed in discussion with AMB and LL. JB
contributed to an initial outline of the paper and
successive drafts to reﬁne the analysis and
content of the paper.
Results
Participants
Thirty-eight participants consented to be inter-
viewed (see Table 1). Four participants had
progressed from a lay PPI role to a professional
research or research support role since becoming
involved in research.
Themes
Four broad themes emerged from the analysis
and are presented below: (i) the impact(s) of
PPI on research; (ii) PPI roles and mechanisms
of impact; (iii) the question of whether or not
the impact of PPI should be assessed; and (iv)
how the impact of PPI should be assessed.
What is the impact of PPI on research?
Participants gave many examples of impact or
potential impact on research, including shaping
initial research questions and ideas, choosing
outcome measures that are relevant and mean-
ingful to patients, ensuring the eﬃcient delivery
of research, helping to solve ethical dilemmas,
improving the way information is communicated
to patients, optimizing the recruitment of partic-
ipants and their experiences of taking part,
collecting and analysing research data, and dis-
seminating research ﬁndings to patients and the
public. Some gave concrete examples of their
own impact on such processes:
Table 1 Self-reported characteristics of interview participants
(N = 38)
Characteristics Number of participants
Male 20
Female 18
Age
18–44 years 5
45–64 years 17
65+ years 16
PPI role*
Patient 24
Carer 9
Dual patient and carer 1
Member of the public 4
Experience of involvement in research
5 years or less 13
5–10 years 12
More than 10 years 13
*Participants preferred many different role names, but for the
purposes of this paper, we have grouped them into these four
categories.
Box 1 Topics covered by the interview guide
Do you feel your involvement has made a
difference so far?
What’s changed because of your involvement?
How/why?
How can we improve the impact of PPI?
Are there any types of research or parts of research
where PPI isn’t useful?
There’s a continuing debate about how we judge
the success of PPI in research and how we measure its
impact. Do you have any thoughts about that?
Do you think we need to measure PPI or capture
its impact?
Do you have any experience of measuring PPI impact?
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. . .it [study] went to ethics and got rejected, and I
can remember the PI [Principal Investigator] com-
ing to me on an email saying, ‘Help!’ . . ..Frankly,
the ethics committee was completely right, the
patient information sheet was a mess. It didn’t
take long to actually sort it out. . .introducing
‘clarity’ is what it’s about. . ..And it sailed through
ethics the second time round. (P26, patient)
Participants did not frame any of the
described impacts on research as negative,
including when PPI resulted in research propos-
als being abandoned:
I said, “I’m thinking about the money you’re going
to be spending on this . . . piece of research.” I said,
“I think it’s a waste of time, I don’t think it’s going
to work the way you want it to pan out”. Anyway
they stopped it. . . (P22, carer)
Importantly, impact did not always mean
‘change’; it could mean validating an existing idea:
I think you’re often a sounding board for people
who’ve already got ideas about how a piece of
research might run. . . but they need someone to
say, “Yeah absolutely that really, really is impor-
tant to us.”. . .. A reassurance that, you know,
what you have in mind actually is valid, impor-
tant. . . It’s not always adding new things; it may
be reinforcing what’s already there. (P40, patient)
Although convinced that PPI beneﬁted
research, some participants found it hard to pin
down the impact of their own involvement:
I don’t actually know what impact I’ve had on any
of it. No, now you come to talk about it, I have
absolutely no idea if anything I have ever done - in
the last eight years - has been of any value to any-
one at all, which is actually quite a sobering
thought. (P32, patient)
Some participants encouraged other PPI con-
tributors to seek feedback from researchers to
increase the value of their contributions. Impact
could change over time and be enhanced
through ongoing, reciprocal feedback:
As you’re leaving the meeting say to the Chair,
“Were those contributions helpful to the meet-
ing?” and get them to tell you if they were. And
say to him, “Look I’m new to this, give me
advice.” I found sometimes that some profession-
als have said to me, “We’d love it if you asked
questions around such and such.” (P27, patient)
Roles and mechanisms of impact
Participants described themselves and their
peers as fulﬁlling a variety of roles in terms of
their ‘added value’. We grouped these into six
broad categories: the expert in lived experi-
ence, the creative outsider, the free challenger,
the bridger, the motivator and the passive
presence (Table 2). These are ﬂuid and not
mutually exclusive, for example the bridger
may connect researchers to the patients they
aim to beneﬁt, thus potentially increasing
their motivation.
We see these roles as functioning within a
team of research professionals and PPI contribu-
tors, as participants stressed the importance of
teamwork in driving impact:
It’s a diﬀerent perspective. It is not better. It is not
inferior. We need the doctor. We need the scientist.
We need the neurologist. We need the PPI. We
need a team. And it’s a team eﬀort that will even-
tually yield the results. (P03, carer)
Should the impact of PPI be assessed?
Participants were generally in favour of assess-
ing the impact of PPI, to improve the way it is
done, to convince sceptical researchers of its
beneﬁts or to reduce tokenistic PPI, to justify the
cost of PPI and to increase funding for PPI:
. . .this is a big investment that we are making, and
so we ought to be contributing something. It’s not
just about having quite a nice time. (P02, carer)
. . .you need to measure things because of the old
adage that what gets measured gets done. And if
you don’t measure things in some way or other
then you have no idea whether you’re doing well
or doing badly. (P09, carer)
And that’s the other thing about impact, you need
to demonstrate it, not just to funders, you need to
demonstrate it to other patients so they will get
involved and think, ‘Yeah I could do this.’ (P40,
patient)
Some participants emphasized the need for
individual feedback regarding their own
impact, as this would improve their contribu-
tions and increase their motivation to
stay involved:
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Table 2 PPI contributors’ perceived roles and mechanisms of impact
Perceived role Proposed mechanism of impact Illustrative quote(s)
The expert in
lived experience
Through their lived experience of a
condition, PPI contributors are
able to consider the acceptability
and feasibility of research
proposals for the target
population
‘And many of these researchers and scientists only ever see
[motor neurone disease] down a microscope, put in a Petri
dish. But its meaning and its effect is unknown to them. I, on
the other hand, am an expert of what it is to live and to die
with motor neurone disease. And that does have a value to
research’. (P03, carer)
‘. . .there was a piece of research about eating in
dementia. . .and they were thinking, is it better for a dementia
person to eat at lunch time rather than in the evening? [. . .]
And I said. . . “I don’t think this study’s going to work, this food
study. . . because a dementia person will not sit down at meal
times, at lunchtime, and eat a full meal.” [. . .] And they must
have listened because like I said they did take it off, they
didn’t bother with it’. (P22, carer)
The creative
outsider
PPI contributors bring a fresh
perspective from outside the
research system, and can help to
solve problems by thinking
‘outside the box’
‘By taking non-experts into any field you can possibly get a
whole leap forward because somebody suggests you look
outside the box and you look at it from a different
perspective’. (P11, patient/carer)
‘Members of the public – because of their different
understandings – can come out with the most bizarre
suggestions. But also, the most incredible suggestions that
actually are the most important’. (P32, patient)
The free
challenger
PPI contributors are able to
challenge researchers without
fear of consequences
‘We can ask the elephant in the room question. We can say,
“Well why not? Why can’t you do this? Well why can’t you do it
that way?” We’re not employed, we don’t have to worry about
the hierarchy in our jobs. . .We can challenge from a purely
interested point of view, not worrying about the bosses or the
NHS or anything really’. (P31, patient)
‘A lot of academics in that group would have a stake in going
forward with the leader because their jobs. . . it depends on
being seen in a good light by the leader. The great advantage
of the citizen researcher is that we don’t. We are volunteers,
we can speak truth to authority without danger of
retribution. . .’ (P24, public)
The bridger PPI contributors bridge the
communication gap between
researchers and patients or the
public, making research more
relevant and accessible
‘That’s one of the main contributions that lay people can make,
“What does that mean? What does that mean for me? What
does that mean for my friends? What will it mean for the
future? Will it make me better? Will it make my auntie better?”
[. . .] And sometimes clinical researchers may not. . . have
thought of the issues with that simplicity so I’m I suppose
making a case for public and patient involvement to make
research as simple as possible in how to understand it, what
it’s going to achieve and how you tell the public about it’.
(P18, public)
The motivator PPI contributors increase
researchers’ motivation/
enthusiasm, for example by
emphasizing how the research will
benefit people.
‘. . . I’ve seen researchers get really very excited about how real
the whole thing seems as opposed to sort of theoretical and
academic. So they can start to see how the research they’re
doing is really going to benefit people so it [PPI] gives a sort of
extra sort of brilliance to it, it makes it more exciting and
engaging’. (P12, patient)
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. . .people tend to give me an idea of how they’re
going to use my information, which of course is
important because that informs how I react to the
next set of reviewing that I do. (P12, patient)
[Feedback from researchers] is a very, very impor-
tant part of the process that isn’t happening. And I
think, actually, that may well be one of the major
parts of the process that keeps people participat-
ing. . . (P32, patient)
However, there was a widespread acknowl-
edgement that assessing the impact of PPI is
challenging, particularly when PPI is a genuinely
collaborative venture. Participant 19 (a patient),
for example, described themselves as ‘just a little
cog’ contributing to ‘moving in the right direc-
tion’. Participant 33 (a patient) felt it was ‘more
diﬃcult to see a direct result of what you’ve done
the more sophisticated you get with your
PPI activity’.
None of the participants appeared to be
unequivocally opposed to assessing the impact
of PPI. However, some were concerned about
assessing impact too simplistically:
. . .if, for instance, you’re holding workshops
where people are talking with each other,
including researchers and, and service users, it’s
quite diﬃcult to then pull apart whose contribu-
tion made which diﬀerence. So those things
make it quite complicated. So I think simplistic
tools for measuring impact can be quite damag-
ing, because they’re not likely to notice it. (P02,
carer)
Participant 41 (a patient) also questioned the
singling out of PPI members rather than others
on the research team: ‘What about the other
people whose expertise you’re asking? Are you
going to measure the impact the statistician had
when you asked him or her to help. . .?’
How should the impact of PPI be assessed?
Participants suggested several ‘impacts’ which
could be quantitatively measured: success in
gaining research funding, research ethics com-
mittee approval and participant recruitment
rates. One participant proposed that increased
demand for PPI in research was itself evidence
of its positive impact:
. . .the biggest indication of our value is that we
can’t keep up with requests for input. And it’s
from people that are really good researchers, very
well-known, but also from some of the young
researchers who’ve heard about us and actually
have come usually via our website and asked for
input. . . So the proof of the pudding’s in the eating
and the number of people that. . .want to buy it.
(P31, patient)
However, participants varied in their attitudes
towards quantitative measurement of impact.
Randomized controlled trials were viewed as the
most convincing type of evidence, but not neces-
sarily appropriate for assessing PPI impact:
So I think some of the diﬃculty of that sort of
question is, well, what do we mean by evidence?
What do we mean by impact? Who is it we’re
trying to convince by this evidence? Because
actually. . . if you’re trying to convince some-
body who only believes in randomised
controlled trials then actually we’re never going
to probably get evidence. Whereas if you’re
going to get evidence for people who. . . will
consider a broader range of research methods
Table 2. Continued
Perceived role Proposed mechanism of impact Illustrative quote(s)
The passive
presence
PPI contributors can change the
way that professionals think just
by being present at meetings.
‘Sometimes, even if we’re just there as a listener, not as an
active contributor, but the professionals know that we are
there, and they try to think from our perspective as well’.
(P06, carer)
‘. . .Afterwards someone says, “You have no idea the
difference that your being there, just being in a room, has
made. . . People are stopping and listening to each other, not
just you, in a different way.”’(P40, patient)
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and their ﬁndings, then I think we can provide
more evidence. (P16, patient)
Qualitative methods were seen as valuable or
essential by some participants because of the
need to capture unintended as well as
intended impacts:
I think [narrative case studies] have got to be part
of it and I think they can start to uncover what
impact is intended and what impact is not intended
as well, which is, I think, something that’s quite
important in these very complex relationships.
(P02, carer)
Some participants spoke of the need to move
beyond ‘anecdotal’ evidence of impact, although
not everyone agreed that ‘anecdotal’ evidence
was a bad thing:
. . .There’s currently a bid out to measure the
impact of PPI [. . .] to ﬁnd tools that measure the
impact. . . Because the only way to get it more
embedded is to actually be able to point to some-
thing that shows – because at the moment it’s
dismissed as anecdotal evidence and I don’t know
why anecdotal evidence doesn’t count. (P36,
patient)
Although relatively tangible impacts were
suggested for assessment, many participants
proposed that the ultimate aim of PPI was to
beneﬁt patients through improved research:
It’s no good just going down some wonderfully
enthusiastic path as a researcher which may or
may not have an impact on the real world. Far bet-
ter to say, well I would ﬁnd it more satisfying to be
able to say at the end of it, “This research had an
impact on hospital practice or what GPs do.” To
me that is such a valuable output from research
that it’s well worth taking a little time at the start
to get lay input. (P39, patient)
There was some discussion about who should
be involved in assessing impact. Some PPI con-
tributors suggested they could keep a record of
their own impact, and some said it was impor-
tant to ask researchers:
You’re going to have to ask investigators, particu-
larly chief investigators, principal investigators,
the ones who actually put studies together in
detail, what their perception of the value is and
hopefully they will do more than give the nomi-
nally appropriate answer. (P26, patient)
Discussion
Main findings
Participants in this study overwhelmingly
expressed the view that PPI has or should have a
beneﬁcial impact on health research, describing
various positive impacts and potential impacts
on research processes which mirror those identi-
ﬁed in systematic reviews.3,4 This is consistent
with the ﬁnding of a recent UK consensus study
that the majority of public participants felt that
PPI leads to research of greater quality and rele-
vance – a view only shared by a minority of
academics.16 In keeping with a qualitative study
of PPI in clinical trials,2 none of the participants
reported negative impacts of PPI on research,
although some expressed uncertainty about the
impact of their own involvement. In our study,
this seemed to be in part because of a lack of
individual feedback on impact within speciﬁc
research projects. Such individual feedback was
seen as an important driver of impact improve-
ment and motivation to stay involved in
research.
Participants described various impactful
roles, which we have referred to as the ‘expert
in lived experience’, the ‘creative outsider’, the
‘free challenger’, the ‘bridger’, the ‘motivator’
and the ‘passive presence’. In practice, these
roles may frequently overlap and PPI contribu-
tors may embody all of them at diﬀerent times
throughout the life of a research project. We
hope that this suggested typology helps
towards better understanding some of the
mechanisms leading to PPI impact, and
towards clarifying what types of impact PPI
contributors and researchers want PPI to have
in research – a crucial step in determining
what impacts to assess and how.15 Determining
which of these roles will be prioritized at the
outset of research projects could help research
teams recruit PPI contributors with the experi-
ence, attributes or skills required to fulﬁl these
roles, and could help to clarify goals at an
early stage. This may in turn help to increase
the perceived value and impact of PPI, as there
appears to be a link between chief investigators
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having goals for PPI in clinical trials and
believing that PPI made a positive diﬀerence.2
Participants generally supported the idea of
PPI impact assessment, although some ques-
tioned whether or not it was possible to do well,
given the complex nature of PPI. It was pointed
out that the more PPI resembles a partnership,
with PPI contributors being part of a team
alongside researchers and other professionals,
the more diﬃcult it is to isolate the impact of the
PPI. This is an important consideration given
the indication that a ‘fully intertwined’ partner-
ship approach leads to greater positive impact.13
There was some concern about the dangers of
oversimplifying the assessment of PPI impact
and producing distorted results. These views
reﬂect those of many academic and non-
academic stakeholders who took part in a con-
sensus study about PPI evaluation: 89%
expressed the view that PPI impact assessment
was very or fairly important, although many
acknowledged that such assessment was
methodologically challenging.16
The participants in our study expressed a
range of diﬀerent views about what impacts
should be assessed, by whom and how. Given
that many of the people we interviewed were
involved in quantitative clinical studies, it is per-
haps not surprising that there was general
acceptance of a biomedical hierarchy of evidence
(with randomized controlled trials at the top)
and acceptance of a discourse about the need to
demonstrate eﬀectiveness in fairly narrow utili-
tarian terms. Yet people we interviewed also
expressed reservations about applying this para-
digm to PPI – a complex social process – and its
possible unintended consequences.
Strengths and limitations
To our knowledge, this is the ﬁrst in-depth, UK-
wide exploration of PPI contributors’ views on
PPI impact assessment in health research. We
hope the ﬁndings will be considered alongside
the predominantly professional views in current
literature. The purposive sampling strategy and
one-to-one interviews yielded rich data on a
diverse range of views and experiences. In
addition, the authors come from diﬀerent
paradigmatic stances and hold diﬀering views on
whether and how PPI impact should be assessed.
The third author is a PPI contributor herself and
was involved in designing the study and inter-
preting data.
Our study has several limitations. First, the
interviews required participants to recall past
experiences of PPI, which for some participants
stretched back over many years. It may be that
in some cases a lack of information, such as
examples of participants’ own impact or exam-
ples of negative impact on research, reﬂects
recall diﬃculties rather than evidence of absence.
Second, participants may have felt reluctant to
speak critically about an enterprise they have
bought into. The interviewers themselves were
researchers (albeit non-clinical), and this may
have inﬂuenced the way participants spoke
about PPI impact and its assessment, for exam-
ple, softening or omitting disagreement with
prevailing academic views (such as the discourse
of evidence-based practice and the hierarchy of
types of evidence). There remains ample evi-
dence that PPI often takes place in a context of
unequal power relations. As Gibson, Lewando-
Hundt and Blaxter argue, in some circumstances
PPI ‘oﬀers relatively limited opportunities to
inﬂuence decision making or alter agendas’, and
can take the form of a ‘weak public, lacking in
general participatory parity and therefore
unable to challenge the boundaries and dis-
course [of the boards]’.22 Although their study
focused on PPI in service networks rather than
research, their conclusion is strongly resonant.
Finally, the interview guide covered many
diﬀerent topics, of which PPI impact was only
one and probing on this speciﬁc topic was
therefore limited. In retrospect, speciﬁc prob-
ing about the potential negative impacts of
PPI may have yielded useful ﬁndings to com-
plement the positive accounts of PPI
impact elicited.
Implications
We believe that there are several important
implications of our ﬁndings. First, PPI
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contributors should be involved as equal part-
ners in debates and decisions about what
impacts to assess, why and how. Just as
researchers hold a range of diﬀering views about
PPI impact assessment,16 so too do PPI contrib-
utors, and their representation in such debates
and decisions should reﬂect this diversity. Sec-
ond, the six PPI roles we conceptualized may aid
research teams in planning PPI, recruiting and
working with PPI contributors. Prospective, in-
depth research such as ethnography may help to
further uncover the mechanisms by which these
roles lead to impact on research. Third, while
the assessment of some types of PPI impact may
be methodologically challenging, documenting
the contributions of individual PPI contributors
and the incorporation of these contributions
into research projects may be relatively feasible,
and would be welcomed by many PPI contribu-
tors who wish to see what diﬀerence they are
making and increase their potential impact.
Assessing the impact of PPI in isolation may be
perceived as discriminatory,16 therefore, we
would encourage researchers to discuss with
their PPI contributors whether such an
approach would be helpful, and if so, how it
should be done.
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